Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

Speciality: Hematology


Speaker:

Dr. Rajesh Gadia | Hon. Consultant Physician & Senior Consultant in ICU at the K.E.M. Hospital

Description:

A warm welcome to all the medical professionals in this insightful session on understanding the management of elephantiasis of the lower limb. This Virtual Case Study on Elephantiasis of Lower Limb, an initiative by Hidoc Dr., is designed to provide a practical, in-depth look at a complex and often debilitating condition. Elephantiasis, or lymphatic filariasis, is a parasitic infection that leads to a profound and progressive enlargement of body parts, most commonly the legs, due to a blocked lymphatic system. This case-based approach allows us to explore the diagnostic and therapeutic challenges clinicians face in real-world scenarios.

The case study will delve into the clinical presentation, which often begins with mild edema and progresses over years to the characteristic massive swelling. We'll examine the importance of a detailed patient history, including travel to endemic areas, and the role of diagnostic tools such as blood smears to identify the microfilariae that cause the disease. The discussion will also highlight the significant psychosocial impact on patients, who often face social stigma and disability, underscoring the need for a holistic approach to care that includes not just medical intervention but also patient support and education.

Therefore, get an overall knowledge of the best practices in managing elephantiasis of the lower limb. Engage with this virtual case study, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Weight loss trial reports success for breast cancer patients at one year mark

2.

Patients value communication skills from cancer surgeons across six key areas, according to research

3.

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

4.

Reversing the toxic relationship with high doses of chemotherapy in oncology.

5.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot